Please login to the form below

Not currently logged in
Email:
Password:

New head for UK PR Council

PRCA appoints Lansons Communications’ CEO Tony Langham

Tony Langham The Public Relations Consultants Association (PRCA) has announced that Tony Langham will be PR Council chair in 2014-2015.

Lansons Communications' CEO Tony Langham will serve immediately as vice-chairman of the Public Relations Consultants Association's PR Council before taking over as chair next year.

Langham will work alongside outgoing chairman Rob Ettridge – co-founder of Red Lorry Yellow Lorry – for the rest of the year, before replacing him.

An existing member of the PR Council, Langham this year led the Economics of Reputation work stream as part of the Future of PR project. He received a lifetime achievement award from the PRCA in 2004.

Langham has been CEO of Lansons since 1989, before which he worked at Dewe Rogerson and MORI Research. A Fellow of the Chartered Institute of Public Relations, he is also non-executive chairman of financial technology firm unbiased.co.uk.

“I will work to ensure that the PR Council produces projects each year to contribute to the reputation of the profession”, he said. “I will also work to ensure the Council articulates a coherent manifesto to the Board on what the membership wants from the PRCA.”

A think-tank, the PR Council aims to provide best-practice guidance for PR professionals.

14th November 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics